Pre-ART Levels of Inflammation and Coagulation Markers Are Strong Predictors of Death in a South African Cohort with Advanced HIV Disease

Clicks: 273
ID: 111301
2012
Background Levels of high-sensitivity C-reactive protein (hsCRP), interleukin-6 (IL-6), and D-dimer predict mortality in HIV patients on antiretroviral therapy (ART) with relatively preserved CD4+ T cell counts. We hypothesized that elevated pre-ART levels of these markers among patients with advanced HIV would be associated with an increased risk of death following the initiation of ART. Methods Pre-ART plasma from patients with advanced HIV in South Africa was used to measure hsCRP, IL-6 and D-dimer. Using a nested case-control study design, the biomarkers were measured for 187 deaths and two controls matched on age, sex, clinical site, follow-up time and CD4+ cell counts. Odds ratios were estimated using conditional logistic regression. In addition, for a random sample of 100 patients, biomarkers were measured at baseline and 6 months following randomization to determine whether ART altered their levels. Results Median baseline biomarkers levels for cases and controls, respectively, were 11.25 vs. 3.6 mg/L for hsCRP, 1.41 vs. 0.98 mg/L for D-dimer, and 9.02 vs. 4.20 pg/mL for IL-6 (all p
Reference Key
ledwaba2012plospre-art Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Lotty Ledwaba;Jorge A. Tavel;Paul Khabo;Patrick Maja;Jing Qin;Phumele Sangweni;Xiao Liu;Dean Follmann;Julia A. Metcalf;Susan Orsega;Beth Baseler;James D. Neaton;H. Clifford Lane;for the Project Phidisa Biomarkers Team;
Journal PloS one
Year 2012
DOI 10.1371/journal.pone.0024243
URL
Keywords

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

No comments yet. Be the first to comment on this article.